Literature DB >> 16258266

BRCA1 regulates gene expression for orderly mitotic progression.

Insoo Bae1, Jeong Keun Rih, Hee Jeong Kim, Hyo Jin Kang, Bassem Haddad, Alexander Kirilyuk, Saijun Fan, Maria L Avantaggiati, Eliot M Rosen.   

Abstract

Germline mutations of the BRCA1 gene confer an increased risk for breast cancer and ovarian cancer. To study the contribution of BRCA1 to sporadic cancers, which often exhibit reduced BRCA1 expression, we tested the effect of knocking down BRCA1 on gene expression in human prostate (DU-145) and breast (MCF-7) cancer cells. DNA microarray and confirmatory RNA analyses revealed that BRCA1 small interfering (si) RNA caused down-regulation of multiple genes implicated in the mitotic spindle checkpoint (eg., BUB1B, HEC, and STK6), chromosome segregation (eg., ESPL1, NEK2, and PTTG1), centrosome function (eg., ASPM), cytokinesis (eg., PRC1, PLK, and KNSL2), and the progression into and through mitosis (eg., CDC2, and CDC20). Cells treated with BRCA1-siRNA showed attenuation of the mitotic spindle checkpoint; but not several G2 checkpoints. Finally, BRCA1 knockdown caused the accumulation of multinucleated cells, suggesting a defect in cytokinesis. We conclude that BRCA1 regulates gene expression for orderly mitotic progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258266     DOI: 10.4161/cc.4.11.2152

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

1.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

2.  Non-visual arrestins are constitutively associated with the centrosome and regulate centrosome function.

Authors:  Haripriya Shankar; Allison Michal; Ronald C Kern; Dong Soo Kang; Vsevolod V Gurevich; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

3.  BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage.

Authors:  Rahul D Ballal; Tapas Saha; Saijun Fan; Bassam R Haddad; Eliot M Rosen
Journal:  J Biol Chem       Date:  2009-09-21       Impact factor: 5.157

4.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

5.  BRCA1-mediated signaling pathways in ovarian carcinogenesis.

Authors:  Tejaswita M Karve; Xin Li; Tapas Saha
Journal:  Funct Integr Genomics       Date:  2011-09-02       Impact factor: 3.410

6.  BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.

Authors:  H N Hilton; L J Patterson McDonald; N Santucci; F R van der Bent; A Silvestri; J D Graham; C L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-18       Impact factor: 2.673

7.  BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

Authors:  Paola De Luca; Elba S Vazquez; Cristian P Moiola; Florencia Zalazar; Javier Cotignola; Geraldine Gueron; Kevin Gardner; Adriana De Siervi
Journal:  Mol Cancer Res       Date:  2011-06-23       Impact factor: 5.852

8.  Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Hee Jeong Kim; Eliot M Rosen; Sivanesan Dakshanamurthy; Riccardo Rondanin; Riccardo Baruchello; Giuseppina Grisolia; Simoni Daniele; Insoo Bae
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

9.  Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.

Authors:  Jane Bayani; Jana Paderova; Joan Murphy; Barry Rosen; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

10.  Positional analyses of BRCA1-dependent expression in Saccharomyces cerevisiae.

Authors:  Robert V Skibbens; Danielle N Ringhoff; Jutta Marzillier; Lynne Cassimeris; Laura Eastman
Journal:  Cell Cycle       Date:  2008-12-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.